454 life sciences: illuminating the future of genome sequencing and personalized medicine.
Year: 2007
Type: article
Abstract: Imagine going to the doctor with a migraine headache and knowing the next day whether your DNA is to blame. Or better yet, imagine knowing whether your DNA encodes a risk for migraines even before a headache strikes. If 454 Life Sciences’ dream is realized, doctors will be able to quickly and inexpensively unlock the mysteries of patients ’ genomes, revealing indicators of disease susceptibility and shedding light on the potential efficacy of particular drug regimens. Due to advances in technology made by companies like 454 Life Sciences in Branford, Connecticut, personalized genomic medicine is becoming
Source: PubMed Central
Author: Kristin Patrick
Institution: Yale University
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: green
OpenAlex ID: W2230252988